Direct and Indirect Drug Design Approaches for the Development of Novel Tricyclic Antipsychotics: Potential 5-HT<sub><b>2A</b></sub> Antagonist

<table>Limitations of current antipsychotic therapies (a) quetiapine; (b) zotepine.</table>

Journal of Chemistry

fig2

Figure 2

Figure 2: Direct and Indirect Drug Design Approaches for the Development of Novel Tricyclic Antipsychotics: Potential 5-HT<sub><b>2A</b></sub> Antagonist 

Journal of Chemistry

Direct and Indirect Drug Design Approaches for the Development of Novel Tricyclic Antipsychotics: Potential 5-HT2A Antagonist

Figure 2

Direct and Indirect Drug Design Approaches for the Development of Novel Tricyclic Antipsychotics: Potential 5-HT_2A Antagonist